Why is Suven Life Scie. falling/rising?

As of 15-Jul, Suven Life Sciences Ltd is experiencing a price increase, currently at Rs. 297.50, reflecting a rise of Rs. 8.5 or 2.94%. The stock has recently hit a new 52-week high of Rs. 301.35 and has been on a consecutive gain streak for the last four days, accumulating a total return of 11.7% during this period. Over the past week, the stock has outperformed the Sensex, with a return of +9.82% compared to the benchmark's -1.36%. However, despite these positive short-term movements, the company faces significant challenges, including operating losses and a weak long-term fundamental strength, as evidenced by a -49.94% annual growth rate in net sales over the last five years and a negative EBITDA. Additionally, the company has reported negative results for the last three consecutive quarters, which could weigh on investor sentiment.
In the broader market context, while Suven Life Sciences has shown strong performance relative to the Sensex in both the short and long term, the overall market has been less favorable, with the Sensex posting a -1.36% return over the past week. The stock's impressive year-to-date return of +131.25% and its outperformance against the BSE500 over various periods highlight its potential; however, the declining participation from institutional investors, who have reduced their stake by -1.13%, raises concerns about the stock's sustainability. This combination of strong short-term gains alongside significant operational challenges and reduced institutional interest creates a complex picture for potential investors.